No abstract available
MeSH terms
-
Antineoplastic Agents / economics
-
Antineoplastic Agents / therapeutic use*
-
Cost-Benefit Analysis
-
Drug Approval / organization & administration
-
England
-
Europe
-
Evidence-Based Medicine
-
Humans
-
Neoplasms / drug therapy*
-
Neoplasms / economics
-
Technology Assessment, Biomedical
-
United States
-
United States Food and Drug Administration